The healthcare landscape is rapidly shifting with the expanding demand for antiviral and antimicrobial technologies in fields such as healthcare, construction, packaging, and consumer products. Advances in such areas are paramount for the improvement of hygiene and control of disease spread. From smart textiles to protective coatings and hygienic surfaces, these innovations are transforming the way we approach healthcare and safety across numerous sectors. The market for these technologies is expected to proliferate in the coming years, bolstered by a growing consciousness of infectious disease hazards and a worldwide appetite for protective, hygiene-centric solutions.
Artificial Intelligence (AI) is increasingly recognized for its potential to accelerate research within this field, addressing time, cost, and drug resistance – the traditional barriers to progress. Deployed for predictive modeling, the AI-based approach expedites the screening of molecular structures, narrowing millions of potential compounds down to a select few viable candidates. Deep-learning algorithms have been successful in identifying new antimicrobial peptides and optimizing drug formulations to combat resistant pathogens. Moreover, AI is being integrated into clinical microbiology laboratories to improve rapid infection detection and the identification of resistance genes. AI’s dual role in discovery and diagnostics indicates it as a game-changing tool driving the development of next-generation anti-infective technologies.
In terms of the types of antiviral and antimicrobial technology on offer, it includes materials, chemistries, surface treatments, and engineered systems specially designed to deactivate or inhibit viruses, bacteria, and fungi. Some of the prevalent approaches include methodologies based on active ingredients such as metal ions and organic biocides, UV-C germicidal and photocatalytic mechanisms, as well as passive microtopographies that mitigate microbial adhesion. These solutions are available in various forms, including coatings, laminates/films, filters, additives, or device-integrated modules, offering continuous or intermittent protection.
Antiviral and antimicrobial technology is being adopted across multiple environments such as healthcare, consumer, and industrial settings, built infrastructure, transportation, and food systems. The effectiveness of these solutions is contingent on their efficacy spectrum, durability, regulatory compliance, safety, and total cost of ownership.
Interestingly, recent rapid diagnostic technologies present promise in the fight against antimicrobial resistance (AMR). Companies like Sysmex Astrego are leading this trend with their rapid tests, which can promptly identify urinary tract infections and suitable antibiotics within an hour, a drastic improvement from the earlier average turnaround time of 2-3 days.
However, the high cost associated with Research & Development and commercialization of these technologies presents a significant constraint. The development of new novel antimicrobials or advanced coatings involves a meticulous process of regulatory approval, clinical testing, and trials which could span over a decade. Consequently, it has led several pharmaceutical companies to redirect their focus to areas of imminent global need due to the lower return on investment.
That said, the uptick in infection control measures and regulations in healthcare, aviation, and public spaces is creating new opportunities for innovation in antimicrobial technology. With bodies like the CDC advocating the use of antimicrobial coatings to deter healthcare-associated infections, and the rising demand for safer public spaces, companies specializing in antimicrobial products stand to gain significantly by creating more sustainable and effective antiviral solutions.
The domination of metallic ion/oxide-based components like silver, copper, and zinc oxide in this market segment can be attributed to their strong antimicrobial activity, long-lasting protection, widespread acceptance, and proven safety. They are primarily used in healthcare, consumer products, and water treatment segments. The upcoming segments expected to demonstrate the most growth comprise graphene or nanocarbon-based technology, driven by developments in advanced medical devices, smart textiles, and future packaging markets.
Many sectors currently depend on coatings and paints produced with antimicrobial properties for robust protection against bacteria and viruses. This segment of the market is expected to grow with an uptick in the use of antimicrobial additives in polymers due to the rising demand for hygienic packaging for personal care products and medical devices.
Furthermore, plastics and polymers, frequently used in packaging, medical devices, consumer goods, and industrial products, are at the forefront of this market, enabled by their compatibility with antimicrobial additives that provide prolonged protection. Meanwhile, the textiles and nonwovens segment is expected to witness rapid growth thanks to an increase in consumer demand for hygiene-friendly and sustainable fabrics and materials.
The antiviral and antimicrobial technology market is primarily led by healthcare and life sciences. This is primarily due to the immediate need for stringent infection prevention in healthcare settings, the awareness of hospital-acquired infections, and innovative protections in medical equipment.
Direct B2B/OEM integration also dominates the antiviral and antimicrobial technology market. Manufacturers prefer direct associations with original equipment manufacturers to embed their technologies in the product design stage, ensuring quality control, swift product launch, and consumer trust.
Around the globe, North America surpasses other regions in its deployment of antiviral and antimicrobial technologies, mostly due to its comprehensive cloud and data infrastructure, significant enterprise R&D budgets, and numerous platform providers. The Middle East and Africa region is set to show significant growth in this market, given their increased investments in healthcare, infection-control mandates, and enhanced healthcare infrastructure.
Source: https://www.precedenceresearch.com/antiviral-and-antimicrobial-technology-market